Roy Olivier: I mentioned in my script, Resolute brought about $1.35 million of ARR. I think we had about not quite 16 of incremental in the quarter and $135 million of that came from Resolute.
Allen Klee: And then if we’re going to think about there’s still a little left over incremental onetime — well, not recurring type spending related to the things you mentioned mostly next quarter. Is there a way to think of what the magnitude of that might be compared to what you just had in the fiscal first quarter?
Roy Olivier: I think we itemize those costs out that affected this quarter. And of that, the proxy stuff goes away pretty much and the Chairman up goes away pretty much. So it’s really around 350-ish of legal, I would say, is probably a legal over and above normal related to M&A type stuff would be the impact.
Allen Klee: On the M&A that you’re looking at, could you remind us in terms of what you’re looking for, what these new businesses will be doing? What they’ll be contributing to the type of stuff that you offer compared to what you offer today?
William Nurthen: Well, yes, obviously, we have to narrow our comments on this, but we’re looking for unique capability that we do not have today that allows us to provide a unique value proposition to our user base. We also are highly interested in complementary adjacent markets where we’re not as successful as others in. For example, we were very strong in corporate not as strong in academic or government. So people that are showing in academic or government and maybe not in corporate would be of interest to us. And then if I point you back to the investor deck that we’ve used over the last 30 or 60 days, there is a number of capabilities slides that point out here’s where we were when we just had Article Galaxy. Here’s where we were 3 months ago with Article Galaxy Q data and references.
And here’s what Resolute does for us. But even with that Resolute deck, there are a few empty boxes. So the way that we think about it is, is there a capability that we can acquire that also has strong cross-sell capability. They also have strength in a segment of the market that we’re not necessarily strong in that we can acquire that will fill out that portfolio allow us to have another strong cross-sell opportunity both ways. So I would just point you to the currently filed investor deck, which an updated version will be filed probably tomorrow, if not today. And if you go to the slide titled innovation value chain, there are three empty boxes there that are interesting to us in terms of M&A targets as long as they meet the other requirements, which has got to have cross-sell capability, got as some strengths we don’t have, and they’ve got to be accretive to our organic growth and EBITDA targets.
Operator: This concludes the question-and-answer session. I would like to turn the conference back over to Roy Olivier for any closing remarks.
Roy Olivier: Thanks, everyone, for joining us today. And as a reminder, we will again be presenting at the Roth Tech Conference in New York on November 15 and the Southwest IDEAS Conference in Dallas on the 16th. If you’d like to attend, please reach out to 3-part advisers. We look forward to speaking to you in February, and have a great day.
Operator: This concludes today’s conference call. You may disconnect your lines. Thank you for participating, and have a pleasant day.
